Definitive Contract VA24016C0051

Award Date 9/21/16
Potential Completion Date 1/8/18
Potential Value $198K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bakersfield, CA 93304, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing equipment and analytical instruments. The contract, valued at $275,227.48, is for the provision of sequencing equipment and related goods and services. Illumina has a history of providing sequencing systems, reagents, and bioinformatics support to various federal agencies, including the...
This is a $156,818.40 firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina arrays and reagents, with a performance period ending on May 14, 2018. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal agencies, including the NIH,...
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $22,274.30 and is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. The contract does not have a set-aside designation. Illumina is providing the VA with a range of its advanced sequencing instruments, reagents, consumables, and bioinformatics...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $157,400.64 contract is for the delivery of multi-ethnic genotyping kits, with a completion date of May 8, 2018. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA for genomic...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $164,980.62 contract provides reagents to support whole genome sequencing using Illumina's MiSeq and NextSeq 2000 platforms, with a performance period through December 2023. The contract has no set-aside designation. Illumina is a well-established provider of sequencing solutions to federal agencies, having received...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments, to provide an NGS (Next Generation Sequencing) platform. The $162,825 contract has a completion date of September 30, 2021 and does not include any set-aside designation. Through previous prime federal contract awards, Illumina has supplied a range of its sequencing platforms, reagents,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for the provision of Genetic Beadchip Kits. The contract, valued at $398,806.06, does not have a set-aside designation and is set to expire on September 30, 2017. Illumina has a history of providing sequencing instruments, reagents, and support services to various federal agencies,...
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the delivery of various DNA sequencing products and services. The award, valued at $20,294.92, is a delivery order under Illumina's existing contracts with the Department of Veterans Affairs (VA), specifically a Blanket Purchase Agreement valued at $231,165 and an Indefinite Delivery Contract valued at $1,297,062. The contract covers the procurement of...

This is a $198,000.00 firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents for genetic and genomic analysis. The contract is for whole genome sequencing services and does not have a set-aside designation.

Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal agencies like the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs. The contract references an Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to provide sequencing platforms and consumables for biological threat characterization. This new VA contract represents an additional award to Illumina for their specialized genomic sequencing capabilities.

Generated 4/2/25, 5:21 PM